<i>In Vitro</i> Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China
Renru Han, Li Ding, Yang Yang, Yan Guo, Dandan Yin, Shi Wu, Peiyuan Zhi, Demei Zhu, Qingmei Liu, Xiaojuan Tan, Yuanju Zhu, Jay Zhang, Li Li, Fupin Hu
Abstract
It is reported that A. baumannii has emerged as an intractable nosocomial pathogen in hospitals especially when it develops resistance to carbapenems and other antibiotics, which limits treatment options and leads to high mortality. In February 2017, the WHO published a list of ESKAPE pathogens designated “priority status” for which new antibiotics are urgently needed.
Topics & Concepts
TigecyclineBroth microdilutionAcinetobacter baumanniiMicrobiologyColistinImipenemAntimicrobialBiologyAntibioticsAntibiotic resistanceBacteriaMinimum inhibitory concentrationPseudomonas aeruginosaGeneticsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyPharmaceutical and Antibiotic Environmental Impacts